Disclosures for "Real-World Efficacy and Safety of Inebilizumab in Generalized Myasthenia Gravis"
-
Dr. Li has nothing to disclose.
-
The institution of Prof. Zhang has received research support from Novartis.
-
Author has nothing to disclose
-
Prof. jing has nothing to disclose.
-
Dr. WU has nothing to disclose.